Trader consensus favoring no new pandemic before 2028 at 79.5% implied probability reflects limited evidence of any novel pathogen achieving sustained human-to-human transmission with pandemic-scale potential. Current respiratory virus activity remains low globally per WHO surveillance, with influenza and SARS-CoV-2 positivity below seasonal baselines. The expanding Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, now exceeding 8,600 confirmed cases, shows regional containment through contact tracing despite high fatality rates, without international spread beyond limited exported cases. Ongoing H5N1 avian influenza detections in mammals raise zoonotic concerns, yet lack efficient airborne adaptation required for broad outbreaks. Strengthened post-COVID surveillance networks and rapid response protocols further constrain escalation risks over the next 15 months.